首页> 美国卫生研究院文献>other >Semiconductor diode laser device adjuvanting intradermal vaccine
【2h】

Semiconductor diode laser device adjuvanting intradermal vaccine

机译:半导体二极管激光装置佐剂皮内疫苗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A brief exposure of skin to a low-power, non-tissue damaging laser light has been demonstrated to augment immune responses to intradermal vaccination. Both preclinical and clinical studies show that this approach is simple, effective, safe and well tolerated compared to standard chemical or biological adjuvants. Until now, these laser exposures have been performed using a diode-pumped solid-state laser (DPSSL) devices, which are expensive and require labor-intensive maintenance and special training. Development of an inexpensive, easy-to-use and small device would form an important step in translating this technology toward clinical applicationHere we report that we have established a handheld, near-infrared (NIR) laser device using semiconductor diodes emitting either 1061, 1258, or 1301 nm light that costs less than $4,000, and that this device replicates the adjuvant effect of a DPSSL system in a mouse model of influenza vaccination. Our results also indicate that a broader range of NIR laser wavelengths possess the ability to enhance vaccine immune responses, allowing engineering options for the device design.This small, low-cost device establishes the feasibility of using a laser adjuvant approach for mass-vaccination programs in a clinical setting, opens the door for broader testing of this technology with a variety of vaccines and forms the foundation for development of devices ready for use in the clinic.
机译:已经证明,将皮肤短暂暴露于低功率,无组织破坏性的激光中可以增强对皮内疫苗接种的免疫反应。临床前和临床研究均表明,与标准化学或生物佐剂相比,该方法简单,有效,安全且耐受性好。到目前为止,这些激光曝光都是使用二极管泵浦的固态激光(DPSSL)设备进行的,该设备价格昂贵,并且需要劳动密集型维护和特殊培训。开发廉价,易于使用的小型设备将成为将该技术转化为临床应用的重要一步。在这里,我们报道我们已经建立了一种手持式,近红外(NIR)激光设备,该设备使用发射1061、1258的半导体二极管,或成本不到4,000美元的1301 nm光,并且该设备可在流感疫苗接种的小鼠模型中复制DPSSL系统的辅助作用。我们的结果还表明,更广泛的近红外激光波长具有增强疫苗免疫反应的能力,从而为设备设计提供了工程选择。这种小型,低成本的设备确定了将激光佐剂方法用于大规模疫苗接种计划的可行性在临床环境中,为使用各种疫苗对该技术进行更广泛的测试打开了大门,并为开发可在临床上使用的设备奠定了基础。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号